TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
ACHIM Biotherapeutics AB
Closing information (x1000 DKK)
| Closing information | 2025/06 | 2024/06 | 2023/06 |
| Turnover |
1
|
0
|
0 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-136
|
-126
|
-208 |
| EBITDA |
-136
|
-126
|
-208 |
| Total assets |
129
|
99
|
160 |
| Current assets |
129
|
99
|
160 |
| Current liabilities |
26
|
45
|
50 |
| Equity capital |
102
|
53
|
109 |
| - share capital |
75
|
98
|
95 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/06 | 2024/06 | 2023/06 |
| Solvency |
79.1%
|
53.5%
|
68.1% |
| Turnover per employee |
1
|
0
|
0 |
| Profit as a percentage of turnover | -13600% | ||
| Return on assets (ROA) |
-105.4%
|
-127.3%
|
-130.0% |
| Current ratio |
496.2%
|
220.0%
|
320.0% |
| Return on equity (ROE) |
-133.3%
|
-237.7%
|
-190.8% |
| Change turnover |
1
|
0
|
-534 |
| Change turnover % | -100% | ||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/06 | 2024/06 | 2023/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.